PART II: Mastering the Protocols for Optimization of Hormone Replacement - Expand Treatment Options (Jul 12 - 14, 2024)

PART II: Mastering the Protocols for Optimization of Hormone Replacement - Expand Treatment Options is organized by TruBalance Healthcare and will be held from Jul 12 - 14, 2024 at Sheraton Gateway Hotel in Toronto International Airport, Toronto, Ontario, Canada.

Description:
PART II of IV BHRT Series : Mastering the Protocols for Optimization of Hormone Replacement Therapy by the Academy of Preventive & Innovative Medicine by Worldlink Medical

Optimum Audience, Open to All Licensed Healthcare Professionals Across Borders
Medical Doctors, GPs, OB/GYNs, Doctor of Osteopathic Medicine, Endocrinologists, Internal Medicine, Cardiologists, Internists, Physicians Assistants, RNs, RPNs, Nurse Practitioners, Naturopathic Doctors, Geriatricians, Psychiatrists, Plastic Surgeons, Sports, Medicine, Psychotherapists, Gastrointestinal Surgeons, Urologists, and Psychiatrists, etc.

Course Description and Details:
Pre-requisite to attend PART II: You have completed PART I: Discover the Power of BHRT
The course follows advanced concepts and up-to-date research above and beyond BHRT Part I. The 2.5 day workshop will keep you current on the appropriate skills needed to manage everyday HRT related problems. It will serve as a short refresher of HRT but will primarily serve to teach new and alternative therapies not explained previously, as well as introduce management of new conditions such as PCOS, Osteoporosis, Cancer and Hormones and Chronic Fatigue Syndrome.

Other exciting topics to be discussed include the following:

• Alternatives to raising testosterone, including methods that maintain or even may increase fertility in men, such as clomid and HCG.

• The importance of early identification of Polycystic Ovarian Syndrome (PCOS), including recognizing its associated signs and symptoms, atypical presentation, and treatment options to potentially improve fertility and reduce risk of long term health consequences, such as obesity, uterine cancer, nonalcoholic fatty liver disease, and type two diabetes. Also, learning why the word “PCOS” is a poor name and a misnomer for the condition, as it is primarily an endocrine condition.

• Review what the literature shows about how hormones affect cancer progression and knowing when and which hormones may be appropriate and why BHRT PART II goes into greater depth than the nuts and bolts covered in BHRT PART I, showcasing literature reviews that highlights the many benefits of HRT, particularly as they pertain to cardiovascular and cancer protection. We also review the scientific literature supporting a more preventive approach to chronic disease vs a sick care model that never treats root causes.

Over 200 peer-reviewed articles, the foundation for Dr. Rouzier’s advanced course will be provided as a reference for the participant. This is the same lecture Dr. Rouzier gives to medical academies to inform physicians of the health benefits of age management therapies.

Course Objectives:
Upon completion of this workshop, the healthcare professional will be able to:

• Identify important issues in the relationship between hormones and cancer: cause, provocation, or protection?

• Outline problem-solving techniques for difficult cases complicated by simultaneous disease processes and the potential benefits of hormones. • Discuss literature citing new indications, risks, benefits, and complications of estrogen, progesterone, and testosterone therapy.

• Determine advanced treatment modalities and dosing strategies for estrogen and progesterone, including new and specific approaches to these therapies.

• Describe important aspects of the WHI findings: identify the experts that refute this study and other factors not included in the trials that would change the conclusions.

• Determine advanced treatment modalities, including new and specific approaches to thyroid, and testosterone replacement for disease prevention.

• Discuss over 40 articles that demonstrate thyroid replacement does not cause osteoporosis, even in TSH suppressive doses.

• Identify various new therapies for erectile/sexual dysfunction in men and women.

• Evaluate the epidemiology of cardiovascular disease and diabetes and the various treatment strategies as they pertain to medication, diet, exercise, and lifestyle changes.

• Describe the strategies for using the new cardiovascular risk markers, inflammation markers, and lipid parameters, as well as how to make sense of all the new lipid fractionation components.

• Determine current screening methods and management strategies for the most common pre-menopausal hormone disorder, Polycystic Ovary Syndrome (PCOS), in addition to implementing diagnostic and treatment strategies for PCOS.

• Apply diagnostic and treatment strategies for hirsutism and hair loss.

• Implement strategies for treating osteoporosis using hormone replacement therapy.

• Provide insightful and clinically meaningful cases to help clinicians improve their practice and patient health outcomes Advisory: The concepts and practice taught are evidence based (we follow the guidelines from the medical studies that prove efficacy) in contrast to what is taught by some groups whose approach is not evidence based (no justifiable scientific reason for what they are teaching and that which is often contrary to evidence based medicine).

Course Schedule:
Friday & Saturday - 8:00AM - 6:00PM EST

Sunday -8:00AM - 12:PM EST

Breakfast & lunch onsite

Course Includes:
E-syllabus + medical references + meals + test + CME credits